NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
May 22, 2026 — HeartBeam (BEAT) develops portable, cable-free ECG system for arrhythmia assessment, aiming to reduce pre-hospital delay and enable clinical-grade cardiac monitoring anywhere.
May 22, 2026 — University of Virginia study reveals how errors in brain cell division may drive cancer and developmental disorders, offering new treatment possibilities.
May 22, 2026 — Regentis Biomaterials (RGNT) advances GelrinC, a cell-free hydrogel implant for knee cartilage repair. FDA trial over 50% enrolled; new manufacturing process boosts yield 400%. Learn about this potential off-the-shelf solution.
May 22, 2026 — LataMed AI Corp. surpasses 1,000 early subscribers and advances mobile healthcare apps for Apple App Store and Google Play, targeting telehealth and AI infrastructure in emerging markets.
May 22, 2026 — The Midwife in Vienna expands on OneLavi.com with three signature products: Baby's First Bath, Baby's Bottom Ointment, and Nipple SOS, offering traditional European holistic care.
May 22, 2026 — Carmed Pharmaceuticals, a Turkey-based company specializing in standardized carvacrol formulations, expands to the U.S. market with a CityBiz Q&A featuring founder Mustafa Can, highlighting products like Vacrol and S-Mix.
May 21, 2026 — SureNano Science (CSE: SURE) advances GEP-44, a novel GLP-1 peptide for obesity, targeting improved tolerability and non-injectable delivery. Learn about its FDA pathway.
May 21, 2026 — Oncotelic Therapeutics integrates 28M scientific abstracts into its PDAOAI AI platform, aiming to revolutionize drug discovery and compete with big pharma. Learn how this small biotech is leveraging AI.
May 21, 2026 — Learn about the progress in developing a lung cancer blood test that could screen beyond smoking history, potentially saving more lives. Includes details on Calidi Biotherapeutics and BioMedWire.
May 21, 2026 — BioAdaptives launches MyndSystem, a 24-hour cognitive support platform with daytime MyndMed and nighttime MyndRenew. Stimulant-free, science-backed, for focus and neural recovery. Available now.
May 21, 2026 — Power Orthodontics brings braces and Invisalign to Halls and Knoxville, TN. Serving children, teens, and adults with traditional braces and clear aligners. Find an orthodontist in Halls TN or Knoxville TN.
May 21, 2026 — Graphene quantum dots (GQDs) interfere with alpha-synuclein aggregation linked to Parkinson's and MSA, as shown in a new STAM study. Intranasal GQDs reduce toxic protein clumps and activate autophagy in mice, offering a promising direction for neurodegenerative disease therapies.
May 20, 2026 — Cardio Diagnostics CEO Dr. Meesha Dogan discusses India expansion and Medicare progress on BioMedWire Podcast, highlighting precision medicine for cardiovascular disease prevention.
May 20, 2026 — Datavault AI and Wellgistics Health form DelivMeds AI, a $4B platform combining AI pharmacy optimization, blockchain smart contracts, and biometric verification for direct-to-consumer healthcare delivery.
May 20, 2026 — Sunshine Biopharma (SBFM) closes $6M public offering to fund generic drug expansion and novel mRNA and antiviral programs. Learn more about the company's pipeline.
May 20, 2026 — Cardio Diagnostics CEO Dr. Meesha Dogan discusses AI-powered precision medicine for heart disease prevention on The BioMedWire Podcast. Expansion into India and Medicare reimbursement progress highlighted.
May 20, 2026 — Datavault AI and Wellgistics Health partner to create DelivMeds AI, a $4B healthcare platform combining AI, blockchain, and biometrics for pharmacy optimization and direct-to-consumer delivery.
May 20, 2026 — UNC researchers develop immunotherapy that destroys acute myeloid leukemia while sparing healthy blood tissue, offering a less toxic alternative to standard treatments.
May 20, 2026 — GeoVax comments on escalating Bundibugyo Ebola outbreak, highlighting MVA-based vaccine platform potential for Ebola, Marburg, and other hemorrhagic fever threats. Preclinical data shows single-dose protection.
May 20, 2026 — Telomir Pharmaceuticals publishes preclinical data showing Telomir-Zn improves survival and reduces oxidative stress in Wilson's disease model, advancing its cancer program.